National
Will Dems embrace marriage in platform?
Renewed debate over LGBT issues as parties prepare for 2012 conventions
Im sure that the Democratic Party platform will be very good if not great on LGBT issues,' said Michael Mitchell, executive director of the National Stonewall Democrats. (Washington Blade file photo by Michael Key)
The Republican National Convention in Tampa Bay, Fla., and the Democratic National Convention in Charlotte, N.C., are 13 months away, but many are already wondering how the two parties will address LGBT issues in their 2012 platforms.
“The platform from 2008 was a pretty good platform, as are most of the platforms of state Democratic parties around the country,” said Michael Mitchell, executive director of the National Stonewall Democrats. “So the vast majority of them are very LGBT inclusive, the vast majority of them talk about everything from the repeal of ‘Don’t Ask, Don’t Tell,’ all the way up to and including marriage in some places. Certainly they vary state to state, given how strong LGBT people are organized in the Democratic Party there.”
Mitchell continued, “So I have no doubt given the people who were involved in 2008 will continue to be involved now, the new crop of people we have coming in. The work that we’re doing at National Stonewall — or rather that we will be doing, as we haven’t started working in earnest on a platform — I’m sure that the platform will be very good if not great on LGBT issues.”
Mitchell sees opportunities to address new LGBT issues in the platform, as several of the 2008 planks have been achieved, including passage of a federal hate crimes law and repeal of “Don’t Ask, Don’t Tell.”
“Our issues have shifted since 2008, so obviously we had the repeal of ‘Don’t Ask, Don’t Tell’ and that’s great … but there are other issues around that implementation that we have to start digging into,” Mitchell continued. “I think it’s certainly better than what the other party is up to.”
The 2008 Republican Party platform denounced same-sex marriage, as well as non-discrimination statutes barring bias on the basis of sexual orientation or gender identity in areas like employment, public accommodations and adoption.
Some moderate Republicans hope that the party will soften its anti-gay rhetoric next year, as public opinion on LGBT issues has shifted.
The DNC’s 2008 platform included a call to repeal “Don’t Ask, Don’t Tell,” increase funding for HIV/AIDS prevention and care, pass the Local Law Enforcement Hate Crimes Prevention Act and assure that federal funds would not be used to “proselytize or discriminate” in “faith-based” programs. The language also explicitly promised to fight discrimination based on sexual orientation and gender identity, and alluded to support for non-discrimination laws in employment.
Most strikingly, the platform stated, “We support the full inclusion of all families, including same-sex couples, in the life of our nation, and support equal responsibility, benefits, and protections. We will enact a comprehensive bipartisan employment non-discrimination act. We oppose the Defense of Marriage Act and all attempts to use this issue to divide us.”
But some LGBT Democrats are looking for more in 2012.
Richard Socarides, president of Equality Matters and a former adviser to President Bill Clinton, wants to see the Democratic Party take a bold stance on issues dear to the LGBT community, including marriage equality.
“I feel it’s important for the Democratic Party to have a strong pro-LGBT platform,” he said. “The platform is very important. It reflects what we stand for. The 2008 platform is not going to be good enough for 2012.
“As we watch the Republican field develop, it seems the GOP platform will be a total disaster,” Socarides said, referring to the 2012 field of GOP presidential candidates.
Members of both parties, however, see 2012 as an opportunity to make headway.
“Log Cabin Republicans plan to actively participate in the process to revise the party’s platform,” said Christian Berle, deputy executive director of Log Cabin Republicans. “We recognize there will be a lot of work to be done to strengthen the importance of reaching out to LGBT Americans as a part of strengthening the party,”
Log Cabin’s chairman emeritus, Bob Kabel, sits on the Republican National Committee, Berle noted. Kabel — Log Cabin’s first national chairman — is the only openly gay member of the RNC, and the first openly gay chairman of a state-level Republican Committee, as the chairman of the District of Columbia Republican Committee.
“Log Cabin Republicans have long had delegates of ours to the conventions and will work with other organizations to help us recruit more openly gay candidates,” Berle said.
Mitchell hopes to bring leaders from across the LGBT community directly to the DNC to communicate goals and ideas to the decision makers.
“I would hope that we are the point organization for other LGBT organizations who are looking to get included in the platform and that we can help guide people to the right folks. That’s the role I really see us as playing.”
Though both parties have a long wait to decide their platforms, Michael Czin, a regional press secretary at the Democratic National Committee, said that as soon as the state parties are ready, the process will begin moving forward.
“The process to draft the 2012 platform hasn’t started yet, but next year there will be a robust and inclusive process within the Democratic Party to draft the 2012 platform,” Czin told the Blade. “The process, just like in previous years will be representative of the many voices that comprise the Democratic Party.”
The platform is forged by the Platform Committee, a diverse group that consists of party delegates from all over the country, representing many constituency groups within the party.
Mitchell said that Stonewall would be able to wield some influence over the process of crafting the platform, especially if prominent LGBT Democrats are involved at high levels during its creation.
“[Stonewall Democrats] have close relationships with the folks who I expect will end up being players,” Mitchell said. “The folks who were all involved the last time around. … We have a lot of those relationships already existing, and I’m sure we’ll be building relationships to figure out the best way to make the platform as LGBT inclusive as possible for both the LGBT community and our families.”
Berle sees a trend of Republican candidates taking less hard-right stances on LGBT issues.
“I think the candidacy of Gov. Jon Huntsman opens a great number of doors for LGBT Republicans to get behind a candidate,” Berle told the Blade. “He has the same position on marriage equality that the president does with his support for civil unions, that is striking a tenor with a wide array of gay and lesbian Americans, not only Republicans but Democrats and independents as well. You have an openly gay candidate in Fred Karger and you have Gov. Gary Johnson and Rep. Ron Paul, whose libertarian positions line up with the views of many LGBT Americans.”
But not everyone sees platform language as relevant to the race, as candidates don’t always tow the party line.
“Party platforms are interesting creatures these days,” said Dana Beyer, executive director of Gender Rights Maryland. “There’s a real dichotomy in my mind. I can’t remember the last time I cared, as a voter, what the platform actually said. Maybe the early 70’s, but it was so long ago I don’t recall.”
She continued, “However, as an activist, and a Democratic candidate, I’m very aware that the platform speaks volumes about the party’s values and priorities. And while it is still a long haul from the enunciation of those values in a platform to their integration into the life of the party’s members, and particularly its leaders, you must start somewhere, and that somewhere is the party platform.”
Chris Barron, board chair of GOProud, played down the importance of platform language.
“Political party platforms are not worth the paper that they’re printed on,” said Barron. “No one in the country reads them, nor should anyone in the country read them. They have absolutely no impact whatsoever. What I care about? I care about the policies that the nominee of each party is going to put forward. That’s what [GOProud will] be focused on.”
Log Cabin’s Berle agrees the presidential nominee holds more sway than the platform committee in the end.
“In terms of the platform — and the convention itself — it will be driven largely through whoever is the Republican nominee, so there are a varying number of candidates who would have different positions in regard to redressing those issues,” Berle said.
Berle speculated that if one of the candidates who has committed to supporting a federal marriage amendment wins the nomination, it will remain part of the platform. However, there are other areas where LGBT Republicans can gain ground, he said.
“It would be a consistent effort of ours to address and debate and hopefully remove the language in support of the ‘Don’t Ask, Don’t Tell’ policy as a part of the platform, particularly because ‘Don’t Ask, Don’t Tell’ in August of 2012 will not exist as a policy,” Berle said. “And it will not exist as a policy because of the support of Republican United States Senators such as Susan Collins and Scott Brown.”
Berle noted that there could be opportunities at the convention level that would expand rights for LGBT Americans, such as support for tax parity legislation that removes the penalty on companies and individuals that cover domestic partners through their health care policies.
When speculating about whether or not the Republican Party would finally nominate a candidate that would speak against anti-LGBT voices in the party, GOProud’s Barron said the party already had in John McCain.
“John McCain went to the floor of the Senate and spoke out eloquently against the Federal Marriage Amendment back when that voice actually mattered,” Barron said. “When there were centrist Democrats who were hiding from this issue, John McCain went to the floor and talked about how it is antithetical to everything that the Republican Party was founded on.”
McCain, however, frustrated his pro-LGBT friends in the Republican Party in 2010 when he became the most outspoken voice fighting the repeal of “Don’t Ask, Don’t Tell” in the Senate. The repeal eventually passed, despite the senator’s protests and filibuster threat.
“I’m confident that we’re going to have a nominee that gay conservatives can work with,” Barron said. “It’s very early in the process, but at the end of the day we’re going to have somebody that gay conservatives can support.”
Federal Government
Holiday week brings setbacks for Trump-Vance trans agenda
Federal courts begin to deliver end-of-year responses to lawsuits involving federal transgender healthcare policy.
While many Americans took the week of Christmas to rest and relax, LGBTQ politics in the U.S. continued to shift. This week’s short recap of federal updates highlights two major blows to the Trump-Vance administration’s efforts to restrict gender-affirming care for minors.
19 states sue RFK Jr. to end gender-affirming care ban
New York Attorney General Letitia James announced on Tuesday that the NYAG’s office, along with 18 other states (and the District of Columbia), filed a lawsuit to stop U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. from restricting gender-affirming care for minors.
In the press release, Attorney General James stressed that the push by the Trump-Vance administration’s crusade against the transgender community — specifically transgender youth — is a “clear overreach by the federal government” and relies on conservative and medically unvalidated practices to “punish providers who adhere to well-established, evidence-based care” that support gender-affirming care.
“At the core of this so-called declaration are real people: young people who need care, parents trying to support their children, and doctors who are simply following the best medical evidence available,” said Attorney General James. “Secretary Kennedy cannot unilaterally change medical standards by posting a document online, and no one should lose access to medically necessary health care because their federal government tried to interfere in decisions that belong in doctors’ offices. My office will always stand up for New Yorkers’ health, dignity, and right to make medical decisions free from intimidation.”
The lawsuit is a direct response to HHS’ Dec. 18 announcement that it will pursue regulatory changes that would make gender-affirming health care for transgender children more difficult, if not impossible, to access. It would also restrict federal funding for any hospital that does not comply with the directive. KFF, an independent source for health policy research, polling, and journalism, found that in 2023 federal funding covered nearly 45% of total spending on hospital care in the U.S.
The HHS directive stems directly from President Donald Trump’s Jan. 28 Executive Order, Protecting Children From Chemical and Surgical Mutilation, which formally establishes U.S. opposition to gender-affirming care and pledges to end federal funding for such treatments.
The American Medical Association, the nation’s largest and most influential physician organization, has repeatedly opposed measures like the one pushed by President Trump’s administration that restrict access to trans health care.
“The AMA supports public and private health insurance coverage for treatment of gender dysphoria and opposes the denial of health insurance based on sexual orientation or gender identity,” a statement on the AMA’s website reads. “Improving access to gender-affirming care is an important means of improving health outcomes for the transgender population.”
The lawsuit also names Oregon, Washington, California, Colorado, Connecticut, Delaware, the District of Columbia, Illinois, Maine, Maryland, Massachusetts, Michigan, Minnesota, New Mexico, Pennsylvania, Rhode Island, Vermont, and Wisconsin as having joined New York in the push against restricting gender-affirming care.
At the HHS news conference last Thursday, Jim O’Neill, deputy secretary of the department, asserted, “Men are men. Men can never become women. Women are women. Women can never become men.”
DOJ stopped from gaining health care records of trans youth
U.S. District Judge Cathy Bissoon blocked an attempt by the Department of Justice (DOJ) to gain “personally identifiable information about those minor transgender patients” from the University of Pittsburgh Medical Center (UPMC), saying the DOJ’s efforts “fly in the face of the Supreme Court.”
Journalist Chris Geidner originally reported the news on Dec. 25, highlighting that the Western District of Pennsylvania judge’s decision is a major blow to the Trump-Vance administration’s agenda to curtail transgender rights.
“[T]his Court joins the others in finding that the government’s demand for deeply private and personal patient information carries more than a whiff of ill intent,” Bissoon wrote in her ruling. “This is apparent from its rhetoric.”
Bissoon cited the DOJ’s “incendiary characterization” of trans youth care on the DOJ website as proof, which calls the practice politically motivated rather than medically sound and seeks to “…mutilate children in the service of a warped ideology.” This is despite the fact that a majority of gender-affirming care has nothing to do with surgery.
In United States v. Skrmetti, the Supreme Court ruled along party lines that states — namely Tennessee — have the right to pass legislation that can prohibit certain medical treatments for transgender minors, saying the law is not subject to heightened scrutiny under the Equal Protection Clause of the Fourteenth Amendment because it does not involve suspect categories like race, national origin, alienage, and religion, which would require the government to show the law serves a compelling interest and is narrowly tailored, sending decision-making power back to the states.
“The government cannot pick and choose the aspects of Skrmetti to honor, and which to ignore,” Judge Bissoon added.
The government argued unsuccessfully that the parents of the children whose records would have been made available to the DOJ “lacked standing” because the subpoena was directed at UPMC and that they did not respond in a timely manner. Bissoon rejected the timeliness argument in particular as “disingenuous.”
Bissoon, who was nominated to the bench by then-President Obama, is at least the fourth judge to reject the DOJ’s attempted intrusion into the health care of trans youth according to Geidner.
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The 25 greatest queer movies of the 21st century so far
How to cope when a partner gives you the silent treatment
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
Holiday week brings setbacks for Trump-Vance trans agenda
Your guide to D.C.’s queer New Year’s Eve parties
Holiday week brings setbacks for Trump-Vance trans agenda
Out actor talks lead role in ‘Fiddler on the Roof’
This gay author sees dead people
